Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization. 2002

Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
Department of Pathology, University of Ulm, Oberer Eselsberg M23, D-89069 Ulm, Germany.

OBJECTIVE The genetic changes underlying the development and progression of prostate cancer are poorly understood. To identify chromosomal regions in incidental prostatic carcinoma (T1a and T1b) was the primary aim of this study. METHODS We used comparative genomic hybridization (CGH) to search for DNA sequence copy number changes on a series of 48 T1 prostate cancer diagnosed by transurethral resection (TURP) and by adenomectomy. Incidental prostatic carcinomas have not been studied by CGH previously. RESULTS CGH analysis indicated that 14 cases (29.2%) of incidental prostatic carcinoma showed chromosome alterations. The most frequent alterations were chromosomal losses of 8p (10.4%), 13q (6.3%), 5q (4.2%) and 18q (4.2%), and gains of 17p (10.4%), 17q (10.4%), 9q (6.3%) and 7q (4.2%). Minimal overlapping chromosomal regions of loss, indicative for the presence of tumor suppressor genes (TSGs), were mapped to 8p22 and 13q14.1-q21.3, and minimal overlapping regions of gain, indicative for the presence of oncogenes, were found at 9q34.2-qter, 17p12 and 17q24-qter. The statistical analysis displayed a significant association between chromosomal aberration detected by CGH and high Gleason score (P < 0.005) as well as between tumor categories T1a and T1b and chromosomal imbalance (P = 0.041). CONCLUSIONS Studies directed at incidental prostatic carcinomas allow discovery of chromosomal changes in small and highly malignant tumors. Our results suggest that loss or gain of DNA in these regions are important in prostate cancer. This is the first study, which documents the spectrum of chromosomal changes in incidental prostatic carcinomas.

UI MeSH Term Description Entries
D008297 Male Males
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
June 2007, Diagnostic molecular pathology : the American journal of surgical pathology, part B,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
January 2009, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
November 2000, Cancer genetics and cytogenetics,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
September 2012, Medical oncology (Northwood, London, England),
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
September 2002, Genes, chromosomes & cancer,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
January 1997, Genes, chromosomes & cancer,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
August 1999, British journal of cancer,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
November 2001, Cancer genetics and cytogenetics,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
September 2004, Leukemia & lymphoma,
Hubertus Wolter, and Danilo Trijic, and Hans-Werner Gottfried, and Torsten Mattfeldt
January 1998, Journal of neuro-oncology,
Copied contents to your clipboard!